Xiaoming Yang
Managing Director @ Sinopharm Capital
Shanghai, China
Xiaoming Yang is a Series A investor at Sinopharm Capital in Shanghai focused on Medical and Biopharma. Xiaoming Yang - Managing Director @ Sinopharm Capital
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Xiaoming Yang invests in
Stages Xiaoming Yang invests in
Countries Xiaoming Yang invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (100%)
- Biopharma 1 (100%)
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Clinical Trials 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Ansun BioPharma
|
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of unique host-directed anti-viral. The company is committed to developing safe and effective immuno-biologic therapies to treat the most vulnerable patients. Its founders were ingenious virologists and molecular biologists who realized that targeting a virusis difficult due to the virus’s ability to mutate and avoid the treatment. This ability to mutate also enables the virus to evade vaccines. So instead of trying to hit a moving target, they developed an innovative new approach to fight respiratory viruses: they targeted the host instead of the virus.The company was founded in 2003 and is headquartered in San Diego, California. | $85M / Series A / May 14, 2018 |
Co-Investors
About Sinopharm Capital
Sinopharm Capital is a private equity arm of China National Pharmaceutical Group Corporation that specializes in medical and healthcare, pharmaceuticals, biotechnology, medical devices, healthcare and medical supply, and services for elderly and persons with disability. It seeks to invest in China. Sinopharm Capital was founded in June 2012 and isbased in Shanghai, China.
Sinopharm Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Aimin Wu
President
|
|||
Fei Jiang
Executive Vice-President
|
|||
|
Shengtao Zhu
Managing Director
|
|||
|
Xiaoming Yang
Managing Director
|
|||
Yong Kuang
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Xiaoming Yang invest in?
Xiaoming Yang invests primarily in Medical, Biopharma and Health Care startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Xiaoming Yang?
Public channels for Xiaoming Yang include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Xiaoming Yang last invest?
The most recent investment recorded for Xiaoming Yang closed in May 2018. Shizune tracks 1 investment in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
